Because inhibition of ESM1 could enhance the abilities of proliferation, migration and invasion of prostate cancer cells in vitro, it was necessary to examine whether this effect could enhance the progression of prostate cancer cells in vivo. The gene discussed is ESM1; the disease is prostate carcinoma.